Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Junaid Tariq

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic ReviewArafat Ali Farooqui, Aqsa Ashraf, Talha Bin Farooq, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2018
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic TransplantationAwais Ijaz, Ali Younas Khan, Saad Ullah Malik, et al.
Critical Reviews in Oncology/Hematology|April 25, 2019
Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunctionMuhammad Asad Fraz, Faiza Hassan Warraich, Sami Ullah Warraich, et al.
The Journal of Clinical Investigation|October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapyPayal Goala, Yongliang Zhang, Nolan Beatty, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Lymphoma, Myeloma & Leukemia|April 16, 2020
Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic ReviewArafat Ali Farooqui, Aqsa Ashraf, Talha Bin Farooq, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
The Th1/Th17 axis regulates chimeric antigen receptor (CAR) T cell therapy toxicitiesPayal Goala, Yongliang Zhang, Cooper Sailer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2018
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic TransplantationAwais Ijaz, Ali Younas Khan, Saad Ullah Malik, et al.
Critical Reviews in Oncology/Hematology|April 25, 2019
Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunctionMuhammad Asad Fraz, Faiza Hassan Warraich, Sami Ullah Warraich, et al.
The Journal of Clinical Investigation|October 30, 2025
IFN-γ-driven skewing towards Th1 over Th17 differentiation underlies CRS and neutropenia in CAR-T therapyPayal Goala, Yongliang Zhang, Nolan Beatty, et al.
Pageof 2